Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  enoxaparin
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-7 of 7 for your search:
Start Over
Comparison of Thromboembolic Events Between Enoxa® and Lovenox® in Patients Undergoing Digestive Cancer
Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: ENOXACARE_med14, NCT02444572
A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: EudraCT number 2007-006033-14, NCT00717938
Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: RC08/118, NCT01356329
Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: RAD052, 2008-002985-70, MD-R20080507, NCT01149304
Anticoagulation Length in Cancer Associated Thrombosis
Phase: Phase II
Type: Supportive care
Status: Approved-not yet active
Age: 16 and over
Sponsor: Other
Protocol IDs: SPON1037-11, 10/145/01, 2012-004117-14, WCTU062, ISRCTN37913976, to be assigned, NCT01817257
Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy
Phase: Phase II
Type: Supportive care
Status: Approved-not yet active
Age: 18 to 89
Sponsor: Other
Protocol IDs: 15-0187, NCT02366871
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: 12-264, NCT01763606
Start Over